New Zealand officials announced on Monday that a 26-year-old’s death has been formally linked to the Pfizer-BioNTech vaccine after he suffered a rare heart inflammation following his first dose of the Covid jab.
In a statement, the country’s Covid-19 Vaccine Independent Safety Monitoring Board, confirmed the myocarditis that had led to his death “was probably due to vaccination.”
He died two weeks after receiving the first dose of Pfizer jab. The victim had never sought medical treatment or advice for his symptoms. Myocarditis can be a side effect from the Pfizer jab. This is an inflammation of your heart muscle that causes irregular heartbeats and reduces blood flow.
This side effect is now linked to the death of another New Zealander. According to the Health Ministry statement, in August, a woman died from rare heart muscle inflammation following her Pfizer vaccination.
Although they cannot be formally linked with the Pfizer vaccine yet, officials confirmed that they are looking into reports about two additional deaths of persons who were given the jab. This included a 13-yearold. While the safety monitoring board said more information about the child’s death was still required, the New Zealand authorities said they believed it was unlikely the second case – the death of a man in his 60s – had been due to the vaccine.
Pfizer has not yet issued a statement to address the news, but a spokesperson for the company said that Pfizer was aware of these reports and still believes the vaccine’s benefits outweigh any potential risks.
According to World Health Organization data, New Zealand has given 7,855,438 Covid jabs since the start of its immunization campaign. While it primarily uses the Pfizer vaccine, officials have also approved the use of those made by Johnson & Johnson and Oxford-AstraZeneca.